BANGKOK, May 24, 2023 /PRNewswire/ A research team at the Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University, has identified "highly effective antibodies against COVID-19" from the human body. These antibodies have been developed into an innovation called "COVITRAP," the world's first nasal spray that traps and inhibits the COVID-19 virus using antibodies. This spray has been certified as a medical device, and the team is confident in its efficacy for dealing with COVID-19 alongside other preventive measures. Although preventive measures for COVID-19 have been relaxed to the point that mask-wearing is not required in some public places, it does not mean that COVID-19 has been entirely eliminated. The virus continues to spread and infect people, making it necessary to remain vigilant and cautious regarding infection prevention, healthcare, vaccination, and mask-wearing. But how beneficial would it be if we had help stopping CO
Do particles hold the power to pave the way for new drugs? In this interview, we speak to Ben Knappett, head of science and applications at Particle Works to find out more!
MyJournals.org - Science - [ASAP] Analysis of Peptides and Proteins by Native and SDS Capillary Gel Electrophoresis Coupled to Electrospray Ionization Mass Spectrometry via a Closed-Circuit Coaxial Sheath Flow Reactor Interface (Analytical Chemistry)